These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6799489)

  • 1. Dansyl chloride labeling of Pseudomonas aeruginosa treated with pyocin R1: change in permeability of the cell envelope.
    Uratani Y
    J Bacteriol; 1982 Feb; 149(2):523-8. PubMed ID: 6799489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fluorescent probe response to the interaction of pyocin R1 with sensitive cells.
    Uratani Y; Kageyama M
    J Biochem; 1977 Feb; 81(2):333-41. PubMed ID: 403184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pyocin R1 on the glucose metabolism of sensitive cells of Pseudomonas aeruginosa.
    Kageyama M
    J Biochem; 1978 Dec; 84(6):1373-9. PubMed ID: 104980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical properties of a new flexuous bacteriocin, pyocin F1, produced by Pseudomonas aeruginosa.
    Kuroda K; Kageyama M
    J Biochem; 1979 Jan; 85(1):7-19. PubMed ID: 104991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study on R-type pyocins of Pseudomonas aeruginosa.
    Ohsumi M; Shinomiya T; Kageyama M
    J Biochem; 1980 Apr; 87(4):1119-25. PubMed ID: 6771248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyocin R1 inhibits active transport in Pseudomonas aeruginosa and depolarizes membrane potential.
    Uratani Y; Hoshino T
    J Bacteriol; 1984 Feb; 157(2):632-6. PubMed ID: 6420392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of iron concentration in the growth medium on the sensitivity of Pseudomonas aeruginosa to pyocin S2.
    Ohkawa I; Shiga S; Kageyama M
    J Biochem; 1980 Jan; 87(1):323-31. PubMed ID: 6766926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin.
    Rampling A; Whitby JL; Wildy P
    J Med Microbiol; 1975 Nov; 8(4):531-41. PubMed ID: 812999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple photometric method for determination of the activity of pyrocin R1.
    Kumazaki T; Ishii S
    J Biochem; 1982 Mar; 91(3):817-23. PubMed ID: 6804454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of fluorescence probes to monitor function of the subunit proteins of the MexA-MexB-oprM drug extrusion machinery in Pseudomonas aeruginosa.
    Ocaktan A; Yoneyama H; Nakae T
    J Biol Chem; 1997 Aug; 272(35):21964-9. PubMed ID: 9268332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate.
    Dingemans J; Ghequire MG; Craggs M; De Mot R; Cornelis P
    Microbiologyopen; 2016 Jun; 5(3):413-23. PubMed ID: 26860427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and properties of an S-type pyocin, pyocin AP41.
    Sano Y; Kageyama M
    J Bacteriol; 1981 May; 146(2):733-9. PubMed ID: 6783626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyocin sensitivity of pseudomonas aeruginosa pretreated with antibiotics.
    Stevens GS; Ottolenghi AC
    Can J Microbiol; 1977 May; 23(5):583-8. PubMed ID: 194663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-Type Pyocins Are Diverse Noncontractile Phage Tail-Like Weapons for Killing
    Saha S; Ojobor CD; Li ASC; Mackinnon E; North OI; Bondy-Denomy J; Lam JS; Ensminger AW; Maxwell KL; Davidson AR
    J Bacteriol; 2023 Jun; 205(6):e0002923. PubMed ID: 37260386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of bacteriocin production by clinical Pseudomonas aeruginosa isolates and their potential as therapeutic agents.
    Charkhian H; Soleimannezhadbari E; Bodaqlouei A; Lotfollahi L; Lotfi H; Yousefi N; Shojadel E; Gholinejad Z
    Microb Cell Fact; 2024 Jun; 23(1):175. PubMed ID: 38872163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action of pyocin R1.
    Iijima M
    J Biochem; 1978 Feb; 83(2):395-402. PubMed ID: 416014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Neisseria gonorrhoeae by a bacteriocin from Pseudomonas aeruginosa.
    Morse SA; Vaughan P; Johnson D; Iglewski BH
    Antimicrob Agents Chemother; 1976 Aug; 10(2):354-62. PubMed ID: 825024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phenotypic relations with regard to pyocin sensitivity, of 191 strains of Pseudomonas aeruginosa isolated in a hospital environment].
    Santini G; Targa S; Basaglia M; Marchetti G; Crovatto M
    Boll Ist Sieroter Milan; 1983 Jul; 62(3):242-6. PubMed ID: 6416270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential inhibition of lipid synthesis by the bacteriocin pyocin S2.
    Okawa I; Maruo B; Kageyama M
    J Biochem; 1975 Jul; 78(1):213-23. PubMed ID: 811653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Colicin M-Type Bacteriocin from Pseudomonas aeruginosa Targeting the HxuC Heme Receptor Requires a Novel Immunity Partner.
    Ghequire MGK; Öztürk B
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 29980560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.